Example: Heart Attack

Clinical Trials Sponsored by Epigenomics, Inc

Total 12 results

NCT04027790

Completed

Plasma-based Colorectal Cancer Screening Research & Development

Conditions: Colo-rectal Cancer
NCT03804593

Completed

HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)

Conditions: Cirrhosis, Liver; Hepatic Cirrhosis; Hepatocellular Carcinoma; Liver Cancer
NCT03218423

Recruiting

Longitudinal Performance of Epi proColon

Conditions: Colorectal Cancer; Colorectal Neoplasms
NCT02251782

Completed

Adherence to Minimally Invasive Testing

Conditions: Colorectal Cancer
NCT01580540

Completed

Head to Head Study Epi proColon and FIT

Conditions: Colorectal Cancer
NCT01574677

Withdrawn

Assessment of Septin9 Biomarker for Detection of Colorectal Cancer in Patients With Positive Fecal Immunochemical Test

Conditions: Colorectal Cancer
NCT01329718

Completed

Specimens for Septin 9 Performance

Conditions: Colorectal Cancer
NCT00855348

Completed

PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening

Conditions: Colorectal Cancer
NCT00696345

Completed

Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay

Conditions: Colorectal Cancer
NCT02198092

Completed

Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes

Conditions: Familial Adenomatous Polyposis; Map Syndrome; Lynch Syndrome; Hnpcc; Colorectal Cancer
NCT01653002

Completed

Methylation Level of SHOX2 in Endobronchial Ultrasound With Real-time Guided Transbronchial Needle Aspiration for Lung Cancer Staging

Conditions: Lung Cancer With Mediastinal Lymph Node Involvement
NCT03311152

Recruiting

Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis

Conditions: Hepatocellular Carcinoma; Cirrhosis